Viewing StudyNCT00095901



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00095901
Status: COMPLETED
Last Update Posted: 2018-03-29
First Post: 2004-11-09

Brief Title: Capecitabine For Nasopharyngeal Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
stage II squamous cell carcinoma of the nasopharynx View
recurrent squamous cell carcinoma of the nasopharynx View
stage IV squamous cell carcinoma of the nasopharynx View
stage III squamous cell carcinoma of the nasopharynx View